Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

This study is currently recruiting participants.

Verified by National Cancer Institute (NCI), September 2009

First Received: May 9, 2009 Last Updated: September 5, 2009 History of Changes

Sponsors and Collaborators:	Children's Oncology Group National Cancer Institute (NCI)
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00899990

Purpose

RATIONALE: Collecting and storing samples of tumor tissue, bone marrow, and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing samples of tumor tissue, bone marrow, and blood from patients with Ewing sarcoma.

Condition	Intervention
Sarcoma	Other: biologic sample preservation procedure Other: medical chart review

Study Type:	Observational
Official Title:	A COG Study for Collecting and Banking Ewing Sarcoma Specimens

Resource links provided by NLM:

MedlinePlus related topics: Cancer Soft Tissue Sarcoma

U.S. FDA Resources

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:

Banking of biological specimens, including associated demographic and clinical data [ Designated as safety issue: No ]

Study Start Date:

February 2008

Detailed Description:

OBJECTIVES:

Collect biological specimens, including associated demographic and clinical data, from patients with Ewing sarcoma.
Provide a repository for long-term storage of Ewing sarcoma-related biological materials.
Make collected specimens available to qualified researchers to understand the biology of Ewing sarcoma and correlate these results with demographic and clinical data.

OUTLINE: This is a multicenter study.

Patients undergo collection of tumor specimens, bone marrow, and peripheral blood at diagnosis. Associated demographic and clinical data are collected and archived.

Patients who are not enrolled on a therapeutic clinical trial are followed annually.

PROJECTED ACCRUAL: Not specified.

Eligibility

Ages Eligible for Study:	up to 21 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

DISEASE CHARACTERISTICS:

Diagnosis of Ewing sarcoma, including peripheral primitive neuroectodermal tumor and Askin tumor
- Newly diagnosed or recurrent disease

PATIENT CHARACTERISTICS:

Not specified

PRIOR CONCURRENT THERAPY:

Not specified

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00899990

Show 128 Study Locations

Sponsors and Collaborators

Children's Oncology Group

National Cancer Institute (NCI)

Investigators

Study Chair:	Stephen Lessnick, MD, PhD	University of Utah
Study Chair:	Richard Gorlick, MD	Children's Hospital at Montefiore

More Information

Additional Information:

Clinical trial summary from the National Cancer Institute's PDQ® database This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	CDR0000544202, COG-AEWS07B1
Study First Received:	May 9, 2009
Last Updated:	September 5, 2009
ClinicalTrials.gov Identifier:	NCT00899990 History of Changes
Health Authority:	Unspecified

Keywords provided by National Cancer Institute (NCI):

localized Ewing sarcoma/peripheral primitive neuroectodermal tumor
metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor
recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor
Askin tumor

Study placed in the following topic categories:

Neuroectodermal Tumors, Primitive
Osteosarcoma
Ewing's Sarcoma
Recurrence
Neuroectodermal Tumors
Neoplasms, Connective and Soft Tissue
Sarcoma, Ewing's
Malignant Mesenchymal Tumor
Soft Tissue Sarcomas

Neoplasms, Germ Cell and Embryonal
Peripheral Neuroectodermal Tumor
Sarcoma
Osteogenic Sarcoma
Neuroepithelioma
Ewing's Family of Tumors
Neuroectodermal Tumors, Primitive, Peripheral
Neoplasms, Glandular and Epithelial

Additional relevant MeSH terms:

Neoplasms by Histologic Type
Neuroectodermal Tumors, Primitive
Neoplasms, Nerve Tissue
Osteosarcoma
Neoplasms, Connective and Soft Tissue
Neuroectodermal Tumors
Sarcoma, Ewing's
Neoplasms

Neoplasms, Bone Tissue
Neoplasms, Germ Cell and Embryonal
Sarcoma
Neoplasms, Connective Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors, Primitive, Peripheral
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on September 11, 2009